Bellevue Group Ag Amneal Pharmaceuticals, Inc. Transaction History
Bellevue Group Ag
- $5.93 Billion
- Q3 2024
A detailed history of Bellevue Group Ag transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 76,414 shares of AMRX stock, worth $647,226. This represents 0.01% of its overall portfolio holdings.
Number of Shares
76,414
Previous 62,760
21.76%
Holding current value
$647,226
Previous $398,000
59.55%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$184 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$124 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$104 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$95.6 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$90.8 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.28B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...